Join
Live feed
·
PRReleasevia Quantisnow
Clearmind Medicine Inc. logo
SciSparc Ltd. logo

Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CMND (Clearmind Medicine Inc.), SPRC (SciSparc Ltd.) and more on Quantisnow.